Location

US_SCIENCE_logo_sm

USciences
McNeil Science and Technology Center
Astra Zeneca Auditorium
STC Room 145
723 South 45th Street and Woodland Avenue
Philadelphia, PA 19104

Click Here to Register

Description

Innovators and Investors: The Journey from Entry to Exit

Tuesday, March 3, 2020
7:00 AM– 4:00 PM (Registration Starts at 7:00AM)

Breakfast Buffet, Hot Lunch, and Free Parking are included.

The Life Sciences Collaborative is proud to invite you to our 7th annual conference at USciences in Philadelphia.

Along with a breakfast buffet, lunch, networking with peers/influencers, and free parking, our program will include:

Philadelphia is consistently ranked in the top 10 life sciences clusters in the country, due to our proximity to Big Pharma, excellent research institutions, and robust talent pool. Venture capital funding of Philly-based life sciences companies, while still trailing Boston, San Francisco, San Diego, and others, has grown significantly in the last several years. With our maturing eco-system, now is a great time to start or grow a life sciences company in the region.

However, we realize that emerging life science companies in our region face a lot of challenges. These challenges include navigating the balance between building a business and optimizing scientific progress, sourcing and working with investors, and entering into commercialization.

Come join the Life Sciences Collaborative for our 7th annual conference to hear from both innovators and investors on their journeys to building sustainable and profitable life sciences businesses.

During the program you will hear from experienced founders who will share stories from the trenches on how they started and seeded their business, what they experienced during growth and how they took their company public or exited. We will also hear how investors recognize and decide on when and what to invest in, and who they want to engage with as partners.

The Life Sciences Collaborative would like for you to engage and learn from this year’s event about the challenges and successes of others, while networking with fellow life science colleagues. Whether your life science cycle is set, or you need to redefine how you prepare your business for the future, this event’s objective is for you to learn, share and develop relationships with others within this ever-evolving life sciences landscape.

We look forward to you joining this esteemed group of speakers in what proves to be a great event for learning, engaging and networking.

Individual Presenters

Chris Cashman
Chairman, MBF Therapeutics

Louis P. Kassa III, MBA
Executive VP & COO, Pennsylvania Biotechnology Center of Bucks Co, Baruch S. Blumberg Institute & Hepititis B Foundation

Adam Lohr
Partner & Senior Analyst, RSM US LLP

J. David Owens
Biopharmaceutical Executive, Entrpreneur, Angel Investor, Board Member

Licensing Panel

Ihor Terleckyj (Moderator)
CEO, CuRAGE Therapeutics

Ahmet Hamdi Cavusoglu, Ph.D.
Director, Academnic Venture Exchange

Michael Poisel
Executive Director, PCI Ventures

Steve Nappi
Associate VP of Technology Commercialization & Business Development, Temple University

Paul Jeffrey
Partner, BusStim, Virtual Biotech Accelerator

Pricing Panel

Amy Williams (Moderator)
President and Managing Partner, SageWorks Rx LLC

Shekhar Yerramilli
Founder & CEO, The Guiding Start

Joshua Parks
Founder, Chiral Logic

Dr. Maria Lopes
Former Chief Medical Officer, MagellanRx

Maximilian Vargas, PhD, MBA
Senior Director, US Access Strategy and Account Management, Certara

Funding Panel

Dennis Steadman (Moderator)
President, Steadman Consulting, LLC & Steadman Capital, LLC

Anthony P. Green, PhD
Vice President, Science and Technology, Ben Franklin Technology Partners of Southern Pennsylvania

Daron Evans
Managing Director, PoC Capital

Susan Dillon, PhD
Co-Founder, President and CEO, Aro Biotherapeutics Company

Andrew Olsen
Principal, Boathouse Capital

Exits Panel

Ryan Udell (Moderator)
Partner, Corporate and Securities Group, White and Williams

Adele Oliva
Founding Partner, 1315 Capital

John Gregg
CEO, BalinBac Therapeutics

Matt Steere
Managing Director, Canaccord Financial

Robert P. Ryan, PhD, D.A.B.T.
President & CEO, Innova Therapeutics, Inc.

Innovators and Investors: The Journey from Entry to Exit
Tuesday, March 3, 2020

All sessions, presenters and times are subject to change without notice.
Breakfast & Lunch Buffet, and Free Parking, are included.
  • Full Agenda
  • 7:00 – 8:00 AM

    Registration, Breakfast and Networking


  • 8:15 – 8:30 AM

    Welcome from LSC’s Founder & Co-Chair, Steve Kantor (EVP KEH Insurance Agency)
    Opening Remarks
    from Paul Katz, MD, President of USciences


  • 8:30 – 9:00 AM

    Speaker #1: Chris Cashman
    Chairman, MBF Therapeutics


  • 9:05 – 10:00 AM

    Panel #1: Raising Capital – Real World Lessons

    Moderator: Dennis Steadman; President, Steadman Consulting, LLC and Steadman Capital LLC
    Speakers:
    Anthony P. Green, PhD; Vice President, Science and Technology, Ben Franklin Technology Partners of Southern Pennsylvania
    Daron Evans; Managing Director, PoC Capital
    Susan Dillon, PhD; Co-Founder, President and CEO, Aro Biotherapeutics Company
    Andrew Olsen; Principal, Boathouse Capital


  • Break
    10:00 – 10:25 AM

  • 10:30 – 11:25 AM

    Panel #2: Pricing

    Moderator: Amy Williams; President and Managing Partner, SageWorksRx LLC
    Speakers:
    Shekhar Yerramilli; Founder & CEO, The Guiding Start
    Joshua Parks; Founder, Chiral Logic
    Dr. Maria Lopes; Former Chief Medical Officer, MagellanRx
    Maximilian Vargas, PhD, MBA; Senior Director, US Access Strategy and Account Management, Certara


  • 11:30AM – 12:00 PM

    Speaker #2: Lou Kassa III MBA
    Executive VP & COO, Pennsylvania Biotechnology Center of Bucks Co, Baruch S. Blumberg Institute & Hepatitis B Foundation


  • Lunch & Networking

    12:00 – 12:55 AM


  • 1:00 – 1:55 PM

    Panel #3: Great Expectations: The Real World of Licensing

    Moderator: Ihor Terleckyj; CEO, CuRAGE Therapeutics
    Speakers:
    Ahmet Hamdi Cavusoglu, Ph.D.; Director, Academnic Venture Exchange
    Michael Poisel; Executive Director, PCI Ventures
    Steve Nappi; Associate VP of Technology Commercialization & Business Development, Temple University
    Paul Jeffrey; Partner, BusStim, Virtual Biotech Accelerator


  • 2:00 – 2:55 PM

    Panel #4: Exits

    Moderator: Ryan Udell; Partner, White & Williams
    Speakers:
    Adele Oliva; Founding Partner, 1315 Capital
    John Gregg; CEO, BalinBac Therapeutics
    Matt Steere; Managing Director, Canaccord Financial
    Robert P. Ryan, PhD, D.A.B.T.; President & CEO, Innova Therapeutics, Inc


  • Break
    3:00 – 3:15 PM
  • 3:15 – 3:40 PM

    Speaker #3: Adam Lohr
    Partner & Senior Analyst, RSM US LLP


  • 3:45 – 4:05 PM

    Speaker #4: J. David Owens
    Biopharmaceutical Executive, Entrepreneur, Angel Investor, Board Member


  • Closing Remarks & Break for Networking

    4:05 PM